Y. Takeishi et al., MYOCARDIAL TOMOGRAPHY WITH TECHNETIUM-99M-TETROFOSMIN DURING INTRAVENOUS-INFUSION OF ADENOSINE-TRIPHOSPHATE, The Journal of nuclear medicine, 39(4), 1998, pp. 582-586
The purpose of this study was to determine the biodistribution of Tc-9
9m-tetrofosmin during intravenous infusion of adenosine triphosphate (
ATP) and to evaluate the potential diagnostic value of myocardial tomo
graphy with Tc-99m-tetrofosmin during ATP infusion for the detection o
f coronary artery disease. Methods: Myocardial Tc-99m-tetrofosmin imag
ing with ATP infusion and coronary arteriography were performed on 65
patients with suspected coronary artery disease, ATP was infused intra
venously at a rate of 0.16 mg/kg/min for 5 min, and 370 MBq of Tc-99m-
tetrofosmin was injected 3 min after the start of ATP infusion. Myocar
dial SPECT imags were obtained 60 min later. Then, 740 MBq of Tc-99m-t
etrofosmin was administered at rest, and myocardial SPECT was repeated
. Regional uptakes of Tc-99m-tetrofosmin were scored from 4, normal, t
o 0, no activity. Serial 5-min planar images were obtained in the ante
rior projection at 15, 30, 45 and 60 min after the Tc-99m-tetrofosmin
injection in 10 patients, Heart-to-lung and heart-to-liver count ratio
s were defined from the serial planar images. Results: Adverse effects
of ATP infusion were mild and transient, A heart-to-lung ratio after
ATP infusion was high even at 15 min (3.40 +/- 0.33) and gradually inc
reased with time. A heart-to-liver ratio after ATP was 0.53 +/- 0.40 a
t 15 min and increased with time. A heart-to-liver ratio reached 0.99
+/- 0.25 (p < 0.01) after 45 min and 1.32 +/- 0.36 (p < 0.01) after 60
min, The sensitivity and specificity for detecting coronary artery di
sease by myocardial SPECT with ATP were 89% (39/44) and 86% (18/21), r
espectively. Conclusion: This study shows the favorable biodistributio
n of Tc-99m-tetrofosmin after intravenous infusion of ATP, A one-day i
maging protocol of Tc-99m-tetrofosmin tomography with ATP is feasible
and has high diagnostic accuracy for coronary artery disease.